FDA Drug Recalls

Recalls / Class II

Class IID-66637-001

Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL single patient infusion vial packaged in 5 Units x 20 mL per carton, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Brand name
Propofol
Generic name
Propofol
Active ingredient
Propofol
Route
Intravenous
NDCs
0409-4699, 0409-6010
FDA application
ANDA077908
Affected lot / code info
Lot #: 27-570-DJ, Exp 03/01/15

Why it was recalled

Presence of Particulate Matter: Visible particles embedded in the glass identified during a retain sample inspection.

Recalling firm

Firm
Hospira Inc.
Manufacturer
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
275 N Field Dr, N/A, Lake Forest, Illinois 60045-2579

Distribution

Quantity
70,450 vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-10-11
FDA classified
2013-11-04
Posted by FDA
2013-11-13
Terminated
2014-10-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-66637-001. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Propofol · FDA Drug Recalls